Bahram Valamehr

Companies

• Fate TherapeuticsBoard member Jan 13, 2025 to now¹
• Fate TherapeuticsChief executive officer Jan 13, 2025 to now¹
• Fate TherapeuticsPresident Jan 13, 2025 to now¹
• Fate TherapeuticsChief Development Officer Aug 7, 2018 to Jul 31, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FTFate Therapeutics FATE591,815 shares³$1.1M at $1.88Aug 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 4, 2026Sold 43,947 shares at $2.46 of Fate Therapeutics³
• May 20, 2026Sold 28,946 shares at $1.88 of Fate Therapeutics⁴
• Jan 15, 2026Granted 335,000 shares of Fate Therapeutics⁵
• Jan 9, 2026Sold 5,190 shares at $1.07 of Fate Therapeutics⁶
• Aug 4, 2025Sold 14,466 shares at $1.06 of Fate Therapeutics⁷
• Jan 10, 2025Sold 8,705 shares at $1.54 of Fate Therapeutics⁸
• Jul 29, 2024Granted 200,000 shares of Fate Therapeutics⁹
• Jan 9, 2024Sold 11,271 shares at $4.38 of Fate Therapeutics¹⁰
• Jan 12, 2023Exercised options 423 shares at $1.37 of Fate Therapeutics¹¹
• Jan 10, 2023Sold 10,917 shares at $5.24 of Fate Therapeutics¹²
• Jul 7, 2022Sold 17,158 shares at $30.23 of Fate Therapeutics¹³
• Jul 7, 2022Exercised options 17,158 shares at $2.73 of Fate Therapeutics¹³
• Jul 6, 2022Sold 7,842 shares at $30.07 of Fate Therapeutics¹⁴
• Jul 6, 2022Exercised options 5,842 shares at $2.73 of Fate Therapeutics¹⁴
• Jul 6, 2022Exercised options 2,000 shares at $4.84 of Fate Therapeutics¹⁴
• Mar 14, 2022Sold 100 shares at $34.04 of Fate Therapeutics¹⁵
• Mar 14, 2022Sold 2,960 shares at $33.30 of Fate Therapeutics¹⁵
• Mar 14, 2022Sold 2,195 shares at $32.49 of Fate Therapeutics¹⁵
• Mar 14, 2022Sold 3,067 shares at $31.66 of Fate Therapeutics¹⁵
• Mar 14, 2022Sold 16,678 shares at $30.36 of Fate Therapeutics¹⁵
• Mar 14, 2022Exercised options 25,000 shares at $2.73 of Fate Therapeutics¹⁵
• Jan 25, 2022Granted 33,302 shares of Fate Therapeutics¹⁶
• Jan 11, 2022Sold 418 shares at $49.12 of Fate Therapeutics¹⁷
• Jan 11, 2022Sold 4,152 shares at $48.44 of Fate Therapeutics¹⁷
• Jan 10, 2022Sold 351 shares at $47.17 of Fate Therapeutics¹⁸